New Pain Drug Gets Conditional OK
[Source: CBS 2 Chicago: Health
http://cbs2chicago.com/health]
Drug giant Merck says the Food and Drug Administration wants more information, but is prepared to approve the company's successor drug to recalled pain reliever Vioxx. The FDA wants data on safety and effectiveness.
permalink: comments: feedURL:http://cbs2chicago.com/health/resources_rss.xml
Although it will probably take years for final approval, it is good that new COX-2 agents are on the way to the market. Vioxx was a very useful medication in patients with sulfa allergies since those patients should not get Celebrex or Bextra.
Drug giant Merck says the Food and Drug Administration wants more information, but is prepared to approve the company's successor drug to recalled pain reliever Vioxx. The FDA wants data on safety and effectiveness.
permalink: comments: feedURL:http://cbs2chicago.com/health/resources_rss.xml
Although it will probably take years for final approval, it is good that new COX-2 agents are on the way to the market. Vioxx was a very useful medication in patients with sulfa allergies since those patients should not get Celebrex or Bextra.
Quick Links
Calendar
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
Categories
Archives
Links
My .Mac Page
Private Area
Latinopundit
MacMinute
MacNetJournal
MacNN
Macsurfer
Mac OS X Hints
MedLogs
Medscape
Reuters Health
Slashdot
XML/RSS Feed
Syndicate this site
Search
|
|
Comments powered by
Statistics
Total entries in this blog:
Total entries in this category: 104
Published On: Nov 01, 2004 08:52 PM
Total entries in this category: 104
Published On: Nov 01, 2004 08:52 PM